The most recent short interest data has been released for the 10/31/2017 settlement date, which shows a 2,150,673 share decrease in total short interest for Lexicon Pharmaceuticals, Inc. (LXRX - Get Report), to 13,435,509, a decrease of 13.80% since 10/13/2017. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days (at the average volume) it would take to close out all of the open short positions if every share traded represented a short position being closed. Average daily volume for LXRX at the 10/31/2017 settlement increased to 742,164, as compared to 691,936 at the 10/13/2017 report. That brought "days to cover" down to 18.10, a 19.63% decrease from the 22.53 days to cover calculated at the previous short interest data release.The below chart shows the historical "days to cover" for LXRX at previous short interest release dates: A decreased "days to cover" value could indicate that short sellers are no longer expecting the same decline in stock price they once were, or it could also indicate a long bet elsewhere was closed where LXRX had been shorted as a hedge. The chart below shows the one year performance of LXRX shares, versus its 200 day moving average. Looking at this chart, LXRX's low point in its 52 week range is $8.07 per share, with $18.00 as the 52 week high point — that compares with a last trade of $9.45.
More from Stocks
Cedar Fair Stockholders Enjoy Riding the 'Golden Cross'
Shares of the amusement park operator still look bullish. Here's how to trade it.
3 Earnings Reports Will Be Key for the Market Next Week
There is a good foundation for more positive action in the week ahead.
Stocks Finish Lower, Pulled Down by Boeing, Johnson & Johnson, Weak China Growth
Stocks declined as Boeing and Johnson & Johnson pulled shares down, while China posted its weakest quarterly economic growth rate in nearly three decades, returning investors' attention to the trade talks between Washington and Beijing.
Are Stock Investors Overreacting to China's GDP Lag? One Big Investor Thinks So
Stock investors should take a finer look at China's economy, UBS thinks.